Thoracic Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-10-31 674889986 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：机制;肺癌;肿瘤
经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！

30 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-09-22 ms9000001053108898 来自甘肃省

审稿速度:1.0
偏重的研究方向：肺癌
经验分享：个案 2天被拒枯了

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-06-05 只想毕业来自广东省

偏重的研究方向：基础实验
经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-06-27 ms7000001609282445 来自山东省

最近还收meta分析吗

43 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-04-30 ms3000001340442240 来自广东省

Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-03-05 ms3000001126828781 来自广西

审稿速度:1.0
经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。

41 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2023-02-24 兔兔好运发paper 来自四川省

偏重的研究方向：肺癌;肿瘤
经验分享：投的meta分析，3天被拒

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2022-11-30 ms8000000992057237 来自云南省

…

41 0

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2022-08-31 ms6000001444239145

投稿时让添加审稿人，怎么查谁是审稿人啊

52 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2165916, encodeId=16492165916f1, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：机制;肺癌;肿瘤 经验分享：投稿第二天就是under revrew，然后没有变过状态，目前还没有消息。需要提交原始数据。看了下最近发表的文章，质量都不错，大概都是1-2个月接收，希望自己也会顺利！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=22fb3118685, createdName=674889986, createdTime=Tue Oct 31 15:32:53 CST 2023, time=2023-10-31, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159028, encodeId=b8572159028f8, content=审稿速度:1.0 偏重的研究方向：肺癌 经验分享：个案 2天被拒枯了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dad8612290, createdName=ms9000001053108898, createdTime=Fri Sep 22 01:20:26 CST 2023, time=2023-09-22, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=2140880, encodeId=2beb214088000, content=偏重的研究方向：基础实验 经验分享：想问下最近有投稿这个期刊的吗，审稿快不快呀，我已经投稿一周了，还没有分配编辑，这个时间正常吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=76135202599, createdName=只想毕业, createdTime=Mon Jun 05 11:01:03 CST 2023, time=2023-06-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145118, encodeId=71e0214511808, content=最近还收meta分析吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16686542389, createdName=ms7000001609282445, createdTime=Tue Jun 27 23:07:03 CST 2023, time=2023-06-27, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2129414, encodeId=7b422129414fc, content=Submissions will be subject to an APC if accepted and published in the journal: $2750 USD / £1850 GBP / €2500 EUR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81ca5454976, createdName=ms3000001340442240, createdTime=Sun Apr 30 12:52:16 CST 2023, time=2023-04-30, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2117650, encodeId=032e211e650b5, content=审稿速度:1.0 经验分享：我投的生信，做了验证，第二天就拒了，感觉这个杂志应该不好中的，质量不错的。看了一下近一年这个杂志发的生信，大部分好像都是有细胞实验的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Sun Mar 05 09:55:55 CST 2023, time=2023-03-05, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2116294, encodeId=5621211629450, content=偏重的研究方向：肺癌;肿瘤 经验分享：投的meta分析，3天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230223/3495061b3fd940bfae63e19d5c634f3e/4aae1a7e9e5c4f4f890a29ff7266640b.jpg, createdBy=0b086152617, createdName=兔兔好运发paper, createdTime=Fri Feb 24 16:06:22 CST 2023, time=2023-02-24, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2103592, encodeId=26ee210359292, content=…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fb08409212, createdName=ms8000000992057237, createdTime=Wed Nov 30 21:17:11 CST 2022, time=2022-11-30, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=1242204, encodeId=bfaf124220440, content=投稿时让添加审稿人，怎么查谁是审稿人啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d7dd5495811, createdName=ms6000001444239145, createdTime=Wed Aug 31 08:43:22 CST 2022, time=2022-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861706, encodeId=5c76861e061a, content=审稿速度:2.0 经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78425414000, createdName=ms8838453850558450, createdTime=Wed Jun 10 20:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=)]

2020-06-10 ms8838453850558450

审稿速度:2.0
经验分享：最近跟师姐一人投了一篇，都被接收了，审稿速度还是挺快的，审稿人也很nice，编辑效率很高

173 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务